Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-κB pathways in subtypes of diffuse large B-cell lymphoma
Top Cited Papers
Open Access
- 1 April 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (7) , 3701-3713
- https://doi.org/10.1182/blood-2007-09-111948
Abstract
The activated B cell–like (ABC) subgroup of diffuse large B-cell lymphoma (DLBCL) is characterized by constitutive activation of the nuclear factor-κKeywords
This publication has 63 references indexed in Scilit:
- Role of JAK2 in the pathogenesis and therapy of myeloproliferative disordersNature Reviews Cancer, 2007
- Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphomaLeukemia, 2007
- Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFκBGenes & Development, 2007
- The Bcl-2 apoptotic switch in cancer development and therapyOncogene, 2007
- Erlotinib Effectively Inhibits JAK2V617F Activity and Polycythemia Vera Cell GrowthJournal of Biological Chemistry, 2007
- Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironmentNature Reviews Immunology, 2007
- The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralizedCancer Cell, 2006
- A loss-of-function RNA interference screen for molecular targets in cancerNature, 2006
- STATs in oncogenesisOncogene, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000